Clinical Trial Results

Showing: All studies [change]
Condition: Breast Cancer Location: Londonderry, New Hampshire 25 trials found
New Search
Filter
Trial Phase
Study Type
Atezolizumab + Sacituzumab Govitecan to Prevent Recurrence in TNBC (ASPRIA)
PHASE2INTERVENTIONAL San Francisco, California +4 more
RECRUITING
Exercise in Metastatic Breast Cancer: EMBody
NAINTERVENTIONAL New Haven, Connecticut +4 more
RECRUITING
ETHAN - ET for Male BC
PHASE2INTERVENTIONAL Washington D.C., District of Columbia +4 more
RECRUITING
TeleHealth Resistance Exercise Intervention to Preserve Dose Intensity and Vitality in Elder Breast Cancer Patients
NAINTERVENTIONAL Boston, Massachusetts +3 more
RECRUITING
A Study of LOXO-783 in Patients With Breast Cancer/Other Solid Tumors
PHASE1INTERVENTIONAL Scottsdale, Arizona +4 more
RECRUITING
CONFIRM: Magnetic Resonance Guided Radiation Therapy
NAINTERVENTIONAL Boston, Massachusetts +1 more
RECRUITING
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
PHASE1, PHASE2INTERVENTIONAL Phoenix, Arizona +4 more
RECRUITING
VS-6766+Abema+Fulv in Met HR+/HER- BC
PHASE1, PHASE2INTERVENTIONAL Boston, Massachusetts +2 more
RECRUITING
Comparison of Breast Cancer Screening With CESM to DBT in Women With Dense Breasts
NAINTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
FIH Study of RGT-419B Alone and With Endocrine Therapy in HR-Positive, HER2-Negative Advanced/Metastatic Breast Cancer
PHASE1INTERVENTIONAL La Jolla, California +4 more
RECRUITING
A Study Evaluating the Efficacy and Safety of Inavolisib Plus Fulvestrant Compared With Alpelisib Plus Fulvestrant in Participants With HR-Positive, HER2-Negative, PIK3CA Mutated, Locally Advanced or Metastatic Breast Cancer Post CDK4/6i and Endocrine Combination Therapy
PHASE3INTERVENTIONAL Greenbrae, California +4 more
RECRUITING
A Study to Evaluate the Safety and Tolerability of TOS-358 in Women With HR+ HER2- Breast Cancer
PHASE1INTERVENTIONAL Chicago, Illinois +4 more
RECRUITING
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
PHASE3INTERVENTIONAL Mobile, Alabama +4 more
RECRUITING
Video Education With Result Dependent dIsclosure
NAINTERVENTIONAL Boston, Massachusetts
RECRUITING
First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast Cancer
PHASE1INTERVENTIONAL Tucson, Arizona +4 more
RECRUITING
Abemaciclib and Endocrine Therapy in Older Patients With Breast Cancer.
PHASE2INTERVENTIONAL Duarte, California +4 more
RECRUITING
The PREDICT Registry:
N/AOBSERVATIONAL Scottsdale, Arizona +4 more
RECRUITING
Screening For BCRL In Targeted Therapy For Breast Cancer
N/AOBSERVATIONAL Boston, Massachusetts
RECRUITING
A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
PHASE1, PHASE2INTERVENTIONAL Duarte, California +4 more
RECRUITING
SHARON: A Clinical Trial for Metastatic Cancer Using Chemotherapy and Patients' Own Stem Cells
PHASE1INTERVENTIONAL Boston, Massachusetts +1 more
RECRUITING
The LYMPH Trial - Microsurgical Versus Conservative Treatment of Chronic Breast Cancer Associated Lymphedema
NAINTERVENTIONAL New Haven, Connecticut +4 more
RECRUITING
Testing the Combination of the Anticancer Drugs ZEN003694 and Binimetinib in Patients With Advanced/Metastatic or Unresectable Solid Tumors With RAS Alterations and Triple Negative Breast Cancer
PHASE1INTERVENTIONAL Boston, Massachusetts +3 more
RECRUITING
A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
PHASE1INTERVENTIONAL Gilbert, Arizona +4 more
RECRUITING
IKS014 in Advanced Solid Tumors That Express HER2
PHASE1INTERVENTIONAL Newport Beach, California +4 more
RECRUITING
Scalp Cooling in MBC
PHASE2INTERVENTIONAL Boston, Massachusetts +1 more
RECRUITING
Filter Trials
Trial Phase
Study Type